Views & Analysis Janssen: ‘Open dialogue’ needed with HTAs to improve access The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.
News European Commission approves 2nd IPCEI to sum of €403m The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face